KO vs TRDA · P/E 25, rev $47.94B vs P/E 12, rev $210.8M
The Coca-Cola Company (KO) versus Entrada Therapeutics Inc (TRDA) — a side-by-side from cached financials, not a winner call.
The Coca-Cola Company (KO) is a beverages - non-alcoholic company listed on NYSE. It is led by James Quincey.
Entrada Therapeutics Inc (TRDA) is a biotechnology company listed on US.
Latest reported KO revenue for 2025-12-31 was $47.94B. Net income was $13.11B. Revenue was up 1.9% from 2024-12-31 to 2025-12-31. KO currently screens at market cap $343.90B and trailing P/E 25.1.
Latest reported TRDA revenue for 2024-12-31 was $210.8M. Net income was $65.6M. Revenue was up 63.4% from 2023-12-31 to 2024-12-31. TRDA currently screens at market cap $274.4M and trailing P/E 12.5.
KO currently screens at market cap $343.90B and trailing P/E 25.1. TRDA currently screens at market cap $274.4M and trailing P/E 12.5.
Not investment advice. Open the KO and TRDA stock pages for the full models.
Not investment advice.